These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4862332)

  • 1. Oberex, a new appetite-reducing agent.
    Bjurulf P; Carlström S; Rorsman G
    Acta Med Scand; 1967 Sep; 182(3):273-80. PubMed ID: 4862332
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical evaluation of the activity oof 2 new anorectics].
    Rinetti M; Barbaresi F; Colombi L
    Schweiz Rundsch Med Prax; 1970 Apr; 59(17):633-7. PubMed ID: 4928198
    [No Abstract]   [Full Text] [Related]  

  • 3. Sustained-action phendimetrazine in obesity.
    Hadler AJ
    J Clin Pharmacol J New Drugs; 1968; 8(2):113-7. PubMed ID: 4871210
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical long-term testing of a new appetite depressant Ro 4-5282 (Pondinil)].
    Jenny S; Rhomberg F
    Schweiz Rundsch Med Prax; 1970 Jul; 59(28):1042-4. PubMed ID: 4934638
    [No Abstract]   [Full Text] [Related]  

  • 5. Mazindol, a new non-amphetamine anorexigenic agent.
    Hadler AJ
    J Clin Pharmacol New Drugs; 1972; 12(11):453-8. PubMed ID: 4563662
    [No Abstract]   [Full Text] [Related]  

  • 6. Body weight changes in overweight patients following an appetite suppressant in a controlled environment.
    Sandoval RG; Wang RI; Rimm AA
    J Clin Pharmacol New Drugs; 1971; 11(2):120-4. PubMed ID: 4929289
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic trial of an anorectic agent using the double blind cross-over technic].
    Bienert HR; Uberla K
    Arzneimittelforschung; 1967 Mar; 17(3):336-42. PubMed ID: 4869817
    [No Abstract]   [Full Text] [Related]  

  • 8. A double blind controlled trial of a new anorectic agent AN448.
    Woodhouse SP; Nye ER; Anderson K; Rawlings J
    N Z Med J; 1975 Jun; 81(542):546-9. PubMed ID: 1099491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anorectic effectiveness of various dosages of fenfluramine and placebo: a cooperative study.
    Dent RW; Preston LW
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):132-43. PubMed ID: 809229
    [No Abstract]   [Full Text] [Related]  

  • 10. Anorexigenic activity of intermittent dextroamphetamine with and without meprobamate.
    Noble RE
    Curr Ther Res Clin Exp; 1972 Apr; 14(4):162-7. PubMed ID: 4623595
    [No Abstract]   [Full Text] [Related]  

  • 11. Obesity-depression: clinical evaluation with a new anorexigenic agent.
    Kornhaber A
    Psychosomatics; 1973; 14(3):162-7. PubMed ID: 4604838
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical evaluation of the anorexic activity and safety of 42-548 in children. Report of a clinical trial.
    Sharma RK; Collipp PJ; Rezvani I; Strimas J; Maddaiah VT; Rezvani E
    Clin Pediatr (Phila); 1973 Mar; 12(3):145-9. PubMed ID: 4573674
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical trial of drugs (8): clinical evaluation of the ability of an appetite-reducing drug to stimulate the central nervous system].
    Gadd K; Gunne LM
    Lakartidningen; 1970 Jun; 67():Suppl II:100+. PubMed ID: 4920745
    [No Abstract]   [Full Text] [Related]  

  • 14. Double-blind comparison of placebo and 42-548, a new appetite suppressant, in obese volunteers.
    De Felice EA; Bronstein S; Cohen A
    Curr Ther Res Clin Exp; 1969 May; 11(5):256-62. PubMed ID: 4977396
    [No Abstract]   [Full Text] [Related]  

  • 15. Appetite-suppressant drugs in the management of obesity: the current view.
    Silverstone T
    Int J Obes; 1987; 11 Suppl 3():135-9. PubMed ID: 3440686
    [No Abstract]   [Full Text] [Related]  

  • 16. Subjective effects of two anorexigenic agents--fenfluramine and AN 448 in normal subjects.
    Holmstrand J; Jonsson J
    Postgrad Med J; 1975; 51 Suppl 1():183-6. PubMed ID: 768967
    [No Abstract]   [Full Text] [Related]  

  • 17. Preliminary study on the effects of fenfluramine derivative, 'S992' in man.
    Pawan GL; Payne PM; Sheldrick EC
    Br J Pharmacol; 1971 Feb; 41(2):416P-417P. PubMed ID: 5572311
    [No Abstract]   [Full Text] [Related]  

  • 18. Aminorex fumarate: a double-blind trial and examination for signs of pulmonary arterial hypertension.
    Kew MC
    S Afr Med J; 1970 Apr; 44(14):421-3. PubMed ID: 4910309
    [No Abstract]   [Full Text] [Related]  

  • 19. Phentermine resin as an adjunct in medical weight reduction: a controlled, randomized, double-blind prospective study.
    Truant AP; Olon LP; Cobb S
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):726-38. PubMed ID: 4629111
    [No Abstract]   [Full Text] [Related]  

  • 20. The fenfluramine/phentermine combination for weight loss.
    Garrett SD; Cupp MJ
    Nurse Pract; 1997 Aug; 22(8):166, 168, 170. PubMed ID: 9279853
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.